These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23661632)

  • 1. Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation.
    Russo M; Levine SZ; Demjaha A; Di Forti M; Bonaccorso S; Fearon P; Dazzan P; Pariante CM; David AS; Morgan C; Murray RM; Reichenberg A
    Schizophr Bull; 2014 Jan; 40(1):111-9. PubMed ID: 23661632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis?
    Allardyce J; McCreadie RG; Morrison G; van Os J
    Soc Psychiatry Psychiatr Epidemiol; 2007 Jun; 42(6):429-37. PubMed ID: 17502977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Long-Term Outcomes in First-Admission Psychosis: Does the Hierarchical Taxonomy of Psychopathology Aid DSM in Prognostication?
    Martin EA; Jonas KG; Lian W; Foti D; Donaldson KR; Bromet EJ; Kotov R
    Schizophr Bull; 2021 Aug; 47(5):1331-1341. PubMed ID: 33890112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.
    Salvatore P; Baldessarini RJ; Tohen M; Khalsa HM; Sanchez-Toledo JP; Zarate CA; Vieta E; Maggini C
    J Clin Psychiatry; 2011 Feb; 72(2):183-93. PubMed ID: 20673546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.
    Quattrone D; Di Forti M; Gayer-Anderson C; Ferraro L; Jongsma HE; Tripoli G; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Lasalvia A; Tortelli A; Llorca PM; de Haan L; Velthorst E; Bobes J; Bernardo M; Sanjuán J; Santos JL; Arrojo M; Del-Ben CM; Menezes PR; Selten JP; ; Jones PB; Kirkbride JB; Richards AL; O'Donovan MC; Sham PC; Vassos E; Rutten BP; van Os J; Morgan C; Lewis CM; Murray RM; Reininghaus U
    Psychol Med; 2019 Jun; 49(8):1378-1391. PubMed ID: 30282569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Main Symptomatic Treatment Targets in Suspected and Early Psychosis: New Insights From Network Analysis.
    Jimeno N; Gomez-Pilar J; Poza J; Hornero R; Vogeley K; Meisenzahl E; Haidl T; Rosen M; Klosterkötter J; Schultze-Lutter F
    Schizophr Bull; 2020 Jul; 46(4):884-895. PubMed ID: 32010940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Psychosis Continuum: Testing a Bifactor Model of Psychosis in a General Population Sample.
    Shevlin M; McElroy E; Bentall RP; Reininghaus U; Murphy J
    Schizophr Bull; 2017 Jan; 43(1):133-141. PubMed ID: 27220965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis.
    Dutta R; Greene T; Addington J; McKenzie K; Phillips M; Murray RM
    Schizophr Bull; 2007 Jul; 33(4):868-76. PubMed ID: 17562692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The component structure of the scales for the assessment of positive and negative symptoms in first-episode psychosis and its dependence on variations in analytic methods.
    Tibber MS; Kirkbride JB; Joyce EM; Mutsatsa S; Harrison I; Barnes TRE; Huddy V
    Psychiatry Res; 2018 Dec; 270():869-879. PubMed ID: 30551337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Psychosis Risk States onto the Hierarchical Taxonomy of Psychopathology Using Hierarchical Symptom Dimensions.
    Cowan HR; Williams TF; Schiffman J; Ellman LM; Mittal VA
    Clin Psychol Sci; 2024 Jan; 12(1):3-21. PubMed ID: 38572185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a Lack of Awareness of Cycloid Psychosis Hamper Adequate Treatment for Patients Suffering From This Disorder? A Case Report.
    Hausmann A; Dehning J; Heil M; Mauracher L; Kemmler G; Grunze H
    Front Psychiatry; 2020; 11():561746. PubMed ID: 33281638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom dimensions and outcome in schizophrenia.
    Salokangas RK
    World Psychiatry; 2003 Oct; 2(3):172-8. PubMed ID: 16946931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis superspectrum I: Nosology, etiology, and lifespan development.
    Jonas KG; Cannon TD; Docherty AR; Dwyer D; Gur RC; Gur RE; Nelson B; Reininghaus U; Kotov R
    Mol Psychiatry; 2024 Apr; 29(4):1005-1019. PubMed ID: 38200290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis superspectrum II: neurobiology, treatment, and implications.
    Kotov R; Carpenter WT; Cicero DC; Correll CU; Martin EA; Young JW; Zald DH; Jonas KG
    Mol Psychiatry; 2024 May; 29(5):1293-1309. PubMed ID: 38351173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding Early Psychoses: Unraveling Stable Microstructural Features Associated With Psychopathology Across Independent Cohorts.
    Wang HR; Liu ZQ; Nakua H; Hegarty CE; Thies MB; Patel PK; Schleifer CH; Boeck TP; McKinney RA; Currin D; Leathem L; DeRosse P; Bearden CE; Misic B; Karlsgodt KH
    Biol Psychiatry; 2024 Jun; ():. PubMed ID: 38908657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding Early Psychoses: Unraveling Stable Microstructural Features Associated with Psychopathology Across Independent Cohorts.
    Wang HR; Liu ZQ; Nakua H; Hegarty CE; Thies MB; Patel PK; Schleifer CH; Boeck TP; McKinney RA; Currin D; Leathem L; DeRosse P; Bearden CE; Misic B; Karlsgodt KH
    bioRxiv; 2024 May; ():. PubMed ID: 38766080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The structural stability of negative symptoms over time].
    Wolpe N; Fernandez-Egea E
    BJPsych Open; 2023 Nov; 9(6):e208. PubMed ID: 37920067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains.
    Strauss GP; Ahmed AO; Young JW; Kirkpatrick B
    Schizophr Bull; 2019 Jun; 45(4):725-729. PubMed ID: 30541136
    [No Abstract]   [Full Text] [Related]  

  • 19. DSM-5 self-rated level 1 cross-cutting symptom measure (CCSM1): Proposal for a three-factors model and implications for the assessment of at-risk situations.
    Combaluzier S; Gouvernet B; Launay C; Murphy P
    Encephale; 2024 Oct; 50(5):531-538. PubMed ID: 38142153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dimensional and categorical architecture for the classification of psychotic disorders.
    Peralta V; Cuesta MJ
    World Psychiatry; 2007 Jun; 6(2):100-1. PubMed ID: 18235866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.